Found: 20
Select item for more details and to access through your institution.
Safety of systemic hormone replacement therapy in breast cancer survivors.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Yield of flow cytometry in addition to cytology for lymph node sampling in patients with incidental axillary adenopathy without a concurrent diagnosis of primary breast malignancy.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 677, doi. 10.1007/s10549-021-06473-4
- By:
- Publication type:
- Article
An overview of genetic services delivery for hereditary breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 491, doi. 10.1007/s10549-021-06478-z
- By:
- Publication type:
- Article
Studying the association between breast cancer and renal cell carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 643, doi. 10.1007/s10549-021-06465-4
- By:
- Publication type:
- Article
Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 665, doi. 10.1007/s10549-021-06468-1
- By:
- Publication type:
- Article
A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 513, doi. 10.1007/s10549-021-06460-9
- By:
- Publication type:
- Article
Breast cancer vaccines for treatment and prevention.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 481, doi. 10.1007/s10549-021-06459-2
- By:
- Publication type:
- Article
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 577, doi. 10.1007/s10549-021-06467-2
- By:
- Publication type:
- Article
Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 545, doi. 10.1007/s10549-021-06461-8
- By:
- Publication type:
- Article
Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 589, doi. 10.1007/s10549-021-06466-3
- By:
- Publication type:
- Article
Circulating lipids and breast cancer prognosis in the Malmö diet and cancer study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 611, doi. 10.1007/s10549-021-06462-7
- By:
- Publication type:
- Article
The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 553, doi. 10.1007/s10549-021-06458-3
- By:
- Publication type:
- Article
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 631, doi. 10.1007/s10549-021-06457-4
- By:
- Publication type:
- Article
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 501, doi. 10.1007/s10549-021-06456-5
- By:
- Publication type:
- Article
A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 623, doi. 10.1007/s10549-021-06451-w
- By:
- Publication type:
- Article
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 565, doi. 10.1007/s10549-021-06450-x
- By:
- Publication type:
- Article
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 523, doi. 10.1007/s10549-021-06448-5
- By:
- Publication type:
- Article
Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 535, doi. 10.1007/s10549-021-06438-7
- By:
- Publication type:
- Article
A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 599, doi. 10.1007/s10549-021-06437-8
- By:
- Publication type:
- Article
Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 653, doi. 10.1007/s10549-021-06430-1
- By:
- Publication type:
- Article